Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 5
2013 2
2014 1
2015 1
2016 2
2018 2
2020 1
2021 2
2022 1
2023 1
2024 2
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.
Walker TM, Miotto P, Köser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, Comas I, Posey J, Omar SV, Peto TE, Suresh A, Uplekar S, Laurent S, Colman RE, Nathanson CM, Zignol M, Walker AS; CRyPTIC Consortium; Seq&Treat Consortium; Crook DW, Ismail N, Rodwell TC. Walker TM, et al. Lancet Microbe. 2022 Apr;3(4):e265-e273. doi: 10.1016/S2666-5247(21)00301-3. Lancet Microbe. 2022. PMID: 35373160 Free PMC article.
Asia emerges as a hotbed of diagnostic innovations for tuberculosis.
Bigio J, van Gemert W, Kaiser B, Waning B, Pai M. Bigio J, et al. Among authors: van gemert w. J Clin Tuberc Other Mycobact Dis. 2021 Aug 25;25:100267. doi: 10.1016/j.jctube.2021.100267. eCollection 2021 Dec. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34485710 Free PMC article. No abstract available.
The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
Sylverken AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, Arthur RA, Dumevi RM, Adu-Amoah L, Addofoh N, Okyere PB, Dzata F, Bonsu F, Adusi-Poku Y, Kranzer K, Siroka A, Gemert WV, Dean A, Owusu-Dabo E. Sylverken AA, et al. Among authors: gemert wv. PLoS One. 2021 Jun 10;16(6):e0252819. doi: 10.1371/journal.pone.0252819. eCollection 2021. PLoS One. 2021. PMID: 34111159 Free PMC article.
Diagnostics to support the scaling up of shorter, safer tuberculosis regimens.
Branigan D, Denkinger CM, Furin J, Heitkamp P, Deborggraeve S, van Gemert W, Herrera R, Kondratyuk S, McKenna L, Ndjeka N, Omar SV, Pai M. Branigan D, et al. Among authors: van gemert w. Lancet Microbe. 2023 Oct;4(10):e758-e760. doi: 10.1016/S2666-5247(23)00217-3. Epub 2023 Jul 31. Lancet Microbe. 2023. PMID: 37536352 Free article. No abstract available.
Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.
Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC. Zignol M, et al. Among authors: van gemert w. N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. N Engl J Med. 2016. PMID: 27626523 Free article. No abstract available.
Digital health for the End TB Strategy: developing priority products and making them work.
Falzon D, Timimi H, Kurosinski P, Migliori GB, Van Gemert W, Denkinger C, Isaacs C, Story A, Garfein RS, do Valle Bastos LG, Yassin MA, Rusovich V, Skrahina A, Van Hoi L, Broger T, Abubakar I, Hayward A, Thomas BV, Temesgen Z, Quraishi S, von Delft D, Jaramillo E, Weyer K, Raviglione MC. Falzon D, et al. Among authors: van gemert w. Eur Respir J. 2016 Jul;48(1):29-45. doi: 10.1183/13993003.00424-2016. Epub 2016 May 26. Eur Respir J. 2016. PMID: 27230443 Free PMC article.
Targeted next-generation sequencing of Mycobacterium tuberculosis from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh.
Uddin MKM, Cabibbe AM, Nasrin R, Ghodousi A, Nobel FA, Rahman SMM, Ahmed S, Ather MF, Razzaque SMA, Raihan MA, Modak PK, Berland JL, Gemert WV, Mohsin SMI, Cirillo DM, Banu S. Uddin MKM, et al. Among authors: gemert wv. Emerg Microbes Infect. 2024 Dec;13(1):2392656. doi: 10.1080/22221751.2024.2392656. Epub 2024 Aug 26. Emerg Microbes Infect. 2024. PMID: 39136526 Free PMC article.
Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients' and Healthcare Workers' Perspectives.
Ihesie A, Chukwuogo O, Eneogu R, Daniel OK, Agbaje A, Odume B, Nongo D, Ohikhuai C, Kadiri-Eneh N, Oyelaran O, Obianeri V, Van Gemert W, Masini EO, D'auvergne C, Ochuko U, Anyaike C, Olarewaju SO. Ihesie A, et al. Among authors: van gemert w. Trop Med Infect Dis. 2024 Dec 7;9(12):301. doi: 10.3390/tropicalmed9120301. Trop Med Infect Dis. 2024. PMID: 39728828 Free PMC article.
19 results